相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer
S. Fujiwara et al.
CANCER GENE THERAPY (2011)
Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter
S. L. Longo et al.
CANCER GENE THERAPY (2011)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
J-H Lee et al.
CANCER GENE THERAPY (2010)
Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study
J. Garcia-Castro et al.
CANCER GENE THERAPY (2010)
Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
H. Li et al.
CANCER GENE THERAPY (2010)
Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase-Activatable Oncolytic Measles Virus
Michael D. Muehlebach et al.
CANCER RESEARCH (2010)
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo et al.
CANCER RESEARCH (2010)
A Hypoxia- and α-Fetoprotein-Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas
Oh-Joon Kwon et al.
CLINICAL CANCER RESEARCH (2010)
Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1
Joao D. Dias et al.
CLINICAL CANCER RESEARCH (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
Effect of decorin on overcoming the extracellular matrix barrier for oncolytic virotherapy
I-K Choi et al.
GENE THERAPY (2010)
Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer
P. Castelo-Branco et al.
GENE THERAPY (2010)
TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer
M. F. Ziauddin et al.
GENE THERAPY (2010)
Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
Feorillo Galivo et al.
HUMAN GENE THERAPY (2010)
Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice
Timothy Kottke et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
Elizabeth J. Kelly et al.
JOURNAL OF VIROLOGY (2010)
Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy
Feng Yao et al.
JOURNAL OF VIROLOGY (2010)
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
Juan J. Rojas et al.
MOLECULAR THERAPY (2010)
Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model
Atique U. Ahmed et al.
MOLECULAR THERAPY (2010)
Potent Oncolytic Activity of Raccoonpox Virus in the Absence of Natural Pathogenicity
Laura Evgin et al.
MOLECULAR THERAPY (2010)
Urokinase-Targeted Fusion by Oncolytic Sendai Virus Eradicates Orthotopic Glioblastomas by Pronounced Synergy With Interferon-β Gene
Yuzo Hasegawa et al.
MOLECULAR THERAPY (2010)
Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for Glioblastoma
Darnell T. Josiah et al.
MOLECULAR THERAPY (2010)
Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
Jing-Hua Huang et al.
MOLECULAR THERAPY (2010)
Transcriptional and Translational Dual-regulated Oncolytic Herpes Simplex Virus Type 1 for Targeting Prostate Tumors
Cleo Y. F. Lee et al.
MOLECULAR THERAPY (2010)
Potentiating Cancer Immunotherapy Using an Oncolytic Virus
Byram W. Bridle et al.
MOLECULAR THERAPY (2010)
Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma
Jennifer Altomonte et al.
MOLECULAR THERAPY (2010)
Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy
Stephen H. Thorne et al.
MOLECULAR THERAPY (2010)
Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
Jan Brun et al.
MOLECULAR THERAPY (2010)
Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
Fabrice Le Boeuf et al.
MOLECULAR THERAPY (2010)
Enhanced Antitumor Effects of an Engineered Measles Virus Edmonston Strain Expressing the Wild-type N, P, L Genes on Human Renal Cell Carcinoma
Xin Meng et al.
MOLECULAR THERAPY (2010)
Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma
XueQing Lun et al.
MOLECULAR THERAPY (2010)
Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
Chunsheng Liu et al.
MOLECULAR THERAPY (2010)
Hyaluronidase Expression by an Oncolytic Adenovirus Enhances Its Intratumoral Spread and Suppresses Tumor Growth
Sonia Guedan et al.
MOLECULAR THERAPY (2010)
Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models
Karsten Geletneky et al.
NEURO-ONCOLOGY (2010)
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
C. K. Ingemarsdotter et al.
ONCOGENE (2010)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
Justyna Leja et al.
PLOS ONE (2010)
Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production
Tommy Alain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy
Andrea Worschech et al.
BMC GENOMICS (2009)
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
I. V. Ulasov et al.
BRITISH JOURNAL OF CANCER (2009)
An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors
N. Lei et al.
CANCER GENE THERAPY (2009)
Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer
S. Ganesh et al.
CANCER GENE THERAPY (2009)
Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells
B. J. Passer et al.
CANCER GENE THERAPY (2009)
Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Delta 24-RGD to Human Gliomas
Raymund L. Yong et al.
CANCER RESEARCH (2009)
Antitumoral Immune Response by Recruitment and Expansion of Dendritic Cells in Tumors Infected with Telomerase-Dependent Oncolytic Viruses
Edukulla Ramakrishna et al.
CANCER RESEARCH (2009)
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
Yuqi Jing et al.
CANCER RESEARCH (2009)
Expression of IFN-β Enhances Both Efficacy and Safety of Oncolytic Vesicular Stomatitis Virus for Therapy of Mesothelioma
Candice L. Willmon et al.
CANCER RESEARCH (2009)
Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
Hiroaki Wakimoto et al.
CANCER RESEARCH (2009)
Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo
Stephan Leitner et al.
CLINICAL CANCER RESEARCH (2009)
A Novel A33 Promoter-Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models
Eduardo G. Cafferata et al.
CLINICAL CANCER RESEARCH (2009)
Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter
Inge Peerlinck et al.
CLINICAL CANCER RESEARCH (2009)
Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
Emily K. Mader et al.
CLINICAL CANCER RESEARCH (2009)
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
Robin J. Prestwich et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNA Regulation of Oncolytic Herpes Simplex Virus-1 for Selective Killing of Prostate Cancer Cells
Cleo Y. F. Lee et al.
CLINICAL CANCER RESEARCH (2009)
Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
Erica M. Gomes et al.
CLINICAL CANCER RESEARCH (2009)
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
M. A. Tyler et al.
GENE THERAPY (2009)
A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
J. J. Rojas et al.
GENE THERAPY (2009)
Ad5/3-9HIF-Δ24-VEGFR-1-Ig, an infectivity enhanced, dual-targeted and antiangiogenic oncolytic adenovirus for kidney cancer treatment
K. Guse et al.
GENE THERAPY (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Potent Antitumor Effect of Interleukin-24 Gene in the Survivin Promoter and Retinoblastoma Double-Regulated Oncolytic Adenovirus
Kang Jian Zhang et al.
HUMAN GENE THERAPY (2009)
Cetuximab Retargeting of Adenovirus via the Epidermal Growth Factor Receptor for Treatment of Intraperitoneal Ovarian Cancer
Joanne Morrison et al.
HUMAN GENE THERAPY (2009)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting the Intratumoral Dendritic Cells by the Oncolytic Adenoviral Vaccine Expressing RANTES Elicits Potent Antitumor Immunity
Natalia Lapteva et al.
JOURNAL OF IMMUNOTHERAPY (2009)
In Vivo Retargeting of Adenovirus Type 5 to αvβ6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
Lynda Coughlan et al.
JOURNAL OF VIROLOGY (2009)
Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation
Jie Jin et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68
Yong A. Yu et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Attraction and Activation of Dendritic Cells at the Site of Tumor Elicits Potent Antitumor Immunity
Natalia Lapteva et al.
MOLECULAR THERAPY (2009)
Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter
Pavlos Msaouel et al.
MOLECULAR THERAPY (2009)
Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
Dmitriy Zamarin et al.
MOLECULAR THERAPY (2009)
Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
Sergia Bortolanza et al.
MOLECULAR THERAPY (2009)
Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy
Candice Willmon et al.
MOLECULAR THERAPY (2009)
Expanded Anticancer Therapeutic Window of Hexon-modified Oncolytic Adenovirus
Elena V. Shashkova et al.
MOLECULAR THERAPY (2009)
p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication
Engin Guerlevik et al.
NUCLEIC ACIDS RESEARCH (2009)
Neuroblastoma Cell Lines Contain Pluripotent Tumor Initiating Cells That Are Susceptible to a Targeted Oncolytic Virus
Yonatan Y. Mahller et al.
PLOS ONE (2009)
Tumor Associated Stromal Cells Play a Critical Role on the Outcome of the Oncolytic Efficacy of Conditionally Replicative Adenoviruses
M. Veronica Lopez et al.
PLOS ONE (2009)
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells
Laura Menotti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Use of Tissue-Specific MicroRNA to Control Pathology of Wild-Type Adenovirus without Attenuation of Its Ability to Kill Cancer Cells
Ryan Cawood et al.
PLOS PATHOGENS (2009)
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer
David H. Kirn et al.
NATURE REVIEWS CANCER (2009)
Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus
Elena V. Shashkova et al.
CANCER RESEARCH (2008)
Bioselection of a Gain of Function Mutation that Enhances Adenovirus 5 Release and Improves Its Antitumoral Potency
Alena Gros et al.
CANCER RESEARCH (2008)
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells
Suvobroto Nandi et al.
CANCER RESEARCH (2008)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA
Erkko Ylosmaki et al.
JOURNAL OF VIROLOGY (2008)
The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens
Reinhold Schirmbeck et al.
MOLECULAR THERAPY (2008)
Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
Timothy Kottke et al.
MOLECULAR THERAPY (2008)
Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters
Sergia Bortolanza et al.
HUMAN GENE THERAPY (2007)
Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter
Toshiyoshi Fujiwara et al.
CURRENT CANCER DRUG TARGETS (2007)
A recombinant human enzyme for enhanced interstitial transport of therapeutics
L. H. Bookbinder et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors
MA Thomas et al.
CANCER RESEARCH (2006)
Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer
J Snoeys et al.
MOLECULAR THERAPY (2006)
Development of transcriptionally regulated oncolytic adenoviruses
D Ko et al.
ONCOGENE (2005)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor
M Takahashi et al.
MOLECULAR THERAPY (2002)
分享论文
